Articles On Telix Pharmaceuticals (ASX:TLX)

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ — Telix Pharmace...

After a tough 2025, many investors are still licking their wounds. Several former market darlings suffered sharp selloffs as AI bubble concerns and company-specific issues weighed heavily on sentiment. But history shows that some of the str...

Highlights Bearish market positions reveal changing sentiment across key ASX names Energy, food, healthcare and education stocks remain under scrutiny Weekly disclosures offer insights into risk, valuation and market confide...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

After a poor year, a slew of blue-chip stocks appears poised for a rebound With the right catalyst, share recoveries can be violent and dramatic Institutions will demand remedial action if poor performance persists Many investors prefer t...

The S&P/ASX 200 Index (ASX: XJO) had a good but not exceptional year. During the 12 months, the benchmark index rose 6.8% to finish at 8,714.3 points. Unfortunately, not all shares climbed with the market. For example, the ASX 200 sha...

Highlights Australian-listed brands with global scale Business models built for durability Market positioning within major ASX indices Australian-listed companies with scalable retail and healthcare models highlight ho...

If you are looking for big returns in 2026, then read on! That's because experts believe that the ASX shares in this article have the potential to smash the market next year. Here's what they are recommending to clients for the year ahead:...

Looking ahead in 2026, I think the best investment opportunities on the ASX could come from a mix of proven compounders, long-term growth stories, and businesses that have already shown they can execute through different market conditions....

I'm a big fan of buy and hold investing and believe it is one of the best ways to grow wealth. But which ASX shares could be worth buying and holding for the long term? Let's take a look at three that I think could be wealth generators over...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

With the sun setting on another ‘issues rich’ year for ASX biotechs, Dr Boreham applies his stethoscope to the soaring highlights and cratering lowlights.   As usual we adopt the user-friendly A to Z format. If only drug, device and diagnos...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Line up of Conviction Calls, Best Buys and most favoured sector picks for the year a...

The S&P/ASX 200 Index (ASX: XJO) has had a pre-Christmas surge.  In the last 5 days, it has gained almost 3%.  This is significant when you consider it is up 7% for the entire year.  However there are a few notable ASX 200 shar...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are starting the week in a positive fashion. In morning trade, the radiopharmaceuticals company's shares are up 2% to $12.25. Why are Telix shares charging higher? Investors have been buying the c...

The Aurizon Holdings Ltd (ASX: AZJ) share price could be in focus today after the rail operator announced it will lodge a proposed ten-year Network access undertaking with the Queensland Competition Authority, aiming to provide long-term ce...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The Stockland Corporation Ltd (ASX: SGP) share price is in focus today after the company declared an estimated 1H26 distribution of 9.0 cents per ordinary stapled security. The distribution will be paid on 27 February 2026 to eligible inves...

The Champion Iron Ltd (ASX: CIA) share price is in focus after the company announced a cash tender offer to acquire Norwegian iron ore producer Rana Gruber for NOK 2,930 million (about US$289 million). The transaction is backed by financial...

The NEXTDC Ltd (ASX: NXT) share price is in focus today after the company reported strong progress on its contracted utilisation, jumping 30% to reach 412MW following new customer wins. NEXTDC's pro-forma forward order book also grew signif...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company released an update on its precision medicine portfolio, highlighting positive Phase 3 results for Illuccix in China and progress on key FDA regulatory...

The Monadelphous Group Ltd (ASX: MND) share price is in focus after the engineering company announced a major $250 million construction contract with Rio Tinto Ltd (ASX: RIO) for the Brockman Syncline 1 iron ore development. The project wil...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ — Telix Pharmac...

The Spark New Zealand Ltd (ASX: SPK) share price is in focus after the company announced a new partnership with Challenger Ltd (ASX: CGF), which is set to reduce Spark's net debt by around $240 million in the first half of FY26. What did Sp...

Good arvo, and welcome to HotCopper Highlights, I’m Isaac McIntyre. In this weekly segment, we go through all the most viewed and most discussed stocks on Australia’s #1 finance website. (It’s also worth mentioning this is the last Highligh...

The healthcare sector has been well and truly out of form in 2025. Since the start of the year, the S&P/ASX 200 Health Care index has lost 25% of its value. Although this is very disappointing, it could be setting the stage for a major...

Companies at the smaller end of the register are often overlooked, but there can be some real gems there if you know where to look. The reasons these companies are overlooked are manifold, but often it's a combination of them being too...

Telix Pharmaceuticals Ltd (ASX: TLX) shares have dropped another 2.54% in Tuesday morning trade. At the time of writing, the shares are trading at $12.84 a piece. Over the past month, the global biopharmaceutical company's shares have pl...

A federal ‘advanced overseas finding’ means Recce can claim up to $85 million in R&D tax offsets Radiopharm is ‘grossly mispriced’, says Bell Potter Entropy Neurodynamics treats first patient in binge eating disorder trial   A develop...

Looking to add a few buy-rated S&P/ASX 200 Index (ASX: XJO) shares to your investment portfolio for the holidays? You've come to the right place! Below, we look at two stocks analysts expect to be well-placed to outperform in the year...

highlights Daily ChartWatch scans spotlight notable ASX uptrends and downtrends Gold, coal and diversified miners feature strongly in the latest lists Healthcare and growth names add variety to the current technical picture...

Melbourne-based Telix Pharmaceuticals’ (ASX: TLX) is facing a potential class action lawsuit in the US over allegations that the company misled shareholders regarding the progress it is making with its prostate cancer therapeutic candidates...

Shareholders in Telix Pharmaceuticals Ltd (ASX: TLX) have had a rough year if they bought near the company's 12-month highs, but the good news is one broker at least thinks they'll deliver significant gains over the coming year. RBC Capi...

Highlights Market-wide weakness reshapes sector leadership Select defence, healthcare and mining names regain attention Policy shifts and governance reforms redraw expectations Australian shares softened as global sent...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

If you have a penchant for ASX 200 growth shares like I do, then keep reading! That's because listed below are two shares that analysts are bullish on and believe could be destined for big things in the future. Here's why they are rated as...

Highlights Major Australian leaders show sustained downward price pressure Select growth and technology names face renewed selling pressure A handful of emerging resources and healthcare stocks still trend higher Austr...

Highlights Rising interest targets energy and consumer firms. Covering activity shifts in select ASX names. Weekly changes reveal market sentiment clues. ASX shorts target uranium, lithium, consumer firms like BOE, DMP...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A highly anticipated Fed rate cut in combination with a sooner-than-expected "QE-but...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin An additional news report on the recommendation, valuation, forecast and opinion cha...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

The Charter Hall Group (ASX: CHC) share price is in focus today after the company declared a half-year distribution of 24.83 cents per security, with 85% of the payment franked at a 30% tax rate. What did Charter Hall Group report? Distrib...

The APA Group (ASX: APA) share price is in focus today after S&P Global Ratings reaffirmed its BBB credit rating and improved APA's debt threshold, enabling over $1 billion in extra growth funding. What did APA Group report? S&P af...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are falling on Monday. In morning trade, the ASX biotech stock is down 1% to $14.65. What's going on with Telix shares? Telix shares are falling today despite the announcement from the radiopharma...

The DigiCo Infrastructure REIT (ASX: DGT) share price drew attention today as the company announced Michael Juniper as its new CEO. Juniper's appointment comes alongside a strategic management reshuffle and a continued focus on data centre...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company announced the first patient has been dosed in Part 2 of its ProstACT Global Phase 3 trial for treating advanced prostate cancer. The company also confi...

The next meeting of the US Federal Reserve is on the cards this week, and all eyes are on whether rates will be cut to spur on the US economy. The research team at Wilsons Advisory say the market is pricing in an 89% chance that US rates...

The National Storage REIT (ASX: NSR) share price is in focus after the company announced it has entered into a binding Scheme Implementation Deed with a consortium led by Brookfield and GIC. Under the proposed deal, NSR securityholders will...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ – Telix Pharmace...

A global study links Alzheimer’s disease with kidney malfunction FDA czar Dr Marty Makary outlines the agency’s priorities Pro Medicus fesses up to a cyber breach   The quest for an Alzheimer’s disease cure has taken a new twist, with an...